Comparison of pneumococcal polysaccharide and CRM197-conjugated pneumococcal oligosaccharide vaccines in young and elderly adults

Infection and Immunity

Volumn 65, Issue 1, 1997, Pages 242-247

  Shelly, Mark A ^a   Jacoby, Helen ^a,c   Riley, Gregory J ^a   Graves, Brian T ^a   Pichichero, Michael ^a   Treanor, John J ^a,b  

^a UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^b UNIVERSITY OF ROCHESTER   (United States)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN A; PNEUMOCOCCUS VACCINE;

ACTIVE IMMUNIZATION; ADULT; AGED; AGING; ANTIBODY RESPONSE; ANTIBODY TITER; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG FORMULATION; HUMAN; IMMUNOGENICITY; INFECTION PREVENTION; INJECTION PAIN; INTRAMUSCULAR DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; STREPTOCOCCUS INFECTION; VACCINE PRODUCTION;

EID: 0031024592     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/iai.65.1.242-247.1997     Document Type: Article

References (34)

1. Aaberge, I. S., T. E. Michaelsen, and H. E. Heier. 1990. IgG subclass antibody responses to pneumococcal polysaccharide vaccine in splenectomized, otherwise healthy individuals. Scand. J. Immunol. 31:711-716.
2. AlonsoDeValasco, E., A. F. M. Verheul, J. Verhoef, and H. Snippe. 1995. Streptococcus pneumoniae: virulence factors, pathogenesis, and vaccines. Microbiol. Rev. 59:591-603.
3. Anderson, P., M. Pichichero, and R. A. Insel. 1985. Immunogens consisting of oligosaccharides from the capsule of Haemophilus influenzae type b coupled to diphtheria toxoid or the toxin protein CRM197. J. Clin. Invest. 76:52-59.
4. Austrian, R., R. M. Douglas, G. Schiffman, A. M. Coetzee, H. J. Koornhof, S. Hayden-Smith, and R. D. W. Reid. 1976. Prevention of pneumococcal pneumonia by vaccination. Trans. Assoc. Am. Phys. 89:184-194.
5. Bardardottir, E., S. Jonsson, I. Nonsdottir, A. Sigfussion, and H. Valdimarsson. 1990. IgG subclass response and opsonization of Streptococcus pneumonia after vaccination of healthy adults. J. Infect. Dis. 162:482-488.
6. Borgono, J. M., A. A. McLean, P. P. Vella, A. F. Woodhour, I. Canepa, W. L. Davidson, and M. R. Hilleman. 1978. Vaccination and revaccination with polyvalent pneumococcal polysaccharide vaccines in adults and infants. Proc. Soc. Exp. Biol. Med. 157:148-154.
7. Carlson, A. J., W. L. Davidson, A. A. McLean, P. P. Vella, R. E. Weibel, A. F. Woodhour, and M. R. Hilleman. 1979. Pneumococcal vaccine: dose, revaccination, and coadministration with influenza vaccine. Proc. Soc. Exp. Biol. Med. 161:558-563.
8. Eskola, J., A. K. Takala, E. Kela, E. Pekkanen, R. Kalliokoski, and M. Leinonen. 1992. Epidemiology of invasive pneumococcal infections in children in Finland. JAMA 268:3323-3327.
9. Farr, B. M., B. L. Johnston, D. K. Cobb, M. J. Fisch, T. P. Germanson, K. A. Adal, and A. M. Anglim. 1995. Preventing pneumococcal bacteremia in patients at risk: results of a matched case-control study. Arch. Intern. Med. 155:2336-2340.
10. Fattal-German, M., J. Taillandier, D. Mathieu, and B. Bizzini. 1991. Pneumococcal vaccination of elderly individuals. Vaccine 9:542-544.
11. Fedson, D. S., E. D. Shapiro, F. M. LaForce, M. A. Mufson, D. M. Musher, J. S. Spika, and R. F. Breiman. 1994. Pneumococcal vaccine after 15 years of use: another view. Arch. Intern. Med. 154:2531-2535.
12. Fiebach, N., and W. Beckett. 1994. Prevention of respiratory infections in adults. Arch. Intern. Med. 154:2545-2557.
13. Granoff, D. M., M. H. Rathore, S. J. Holmes, P. D. Granuff, and A. H. Lucas. 1993. Effect of immunity to the carrier protein on antibody responses to Haemophilus influenzae type b conjugate vaccines. Vaccine 11:S44-S49.
14. Hilleman, M. R., A. J. Carlson, Jr., A. A. McLean, P. P. Vella, R. E. Weibel, and A. F. Woodhour. 1981. Streptococcus pneumoniae polysaccharide vaccine: age and dose responses, safety, persistence of antibody, revaccination, and simultaneous administration of pneumococcal and influenza vaccines. Rev. Infect. Dis. 3:S31-S42.
15. Holland, B. S., and M. D. Copenhaver. 1987. An improved sequentially rejective Bonferroni test procedure. Biometrics 43:417-423.
16. Kaniuk, A. S., J. E. Lortan, and M. A. Monteil. 1992. Specific IgG subclass antibody levels and phagocytosis of serotype 14 pneumococcus following immunization. Scand. J. Immunol. 36:96-98.
17. Konradsen, H., and J. Henrichsen. 1991. Antibody responses to pneumococcal vaccination in the elderly. Int. J. Med. Microbiol. 275:94-99.
18. Luc, C., A. Tarkowski, and J. Mestecky. 1988. Systemic immunization with pneumococcal polysaccharide vaccine induces a predominant lgA2 response of peripheral blood lymphocytes and increases of both serum and secretory anti-pneumococcal antibodies. J. Immunol. 140:3793-3800.
19. Mestecky, J. 1987. The common mucosal immune system and current strategies for induction of immune responses in external secretions. J. Clin. Immunol. 7:265-276.
20. Molrine, D. C., S. George, N. Tarbell, P. Mauch, L. Diller, D. Neuberg, and R. C. Shamberger. 1995. Antibody responses to polysaccharide and polysaccharide conjugate vaccines after treatment of Hodgkin's disease. Ann. Intern. Med. 123:828-834.
21. Musher, D. M., M. J. Luchi, D. A. Watson, R. Hamilton, and R. E. Baughn. 1990. Pneumococcal polysaccharide vaccine in young adults and older bronchitics: determination of IgG responses by ELISA and the effect of adsorption of serum with non-type-specific cell wall polysaccharide. J. Infect. Dis. 161:728-735.
22. Nahm, M. Personal communication.
23. Plouffe, J. F., R. F. Breiman, and R. R. Facklam. 1996. Bacteremia with Streptococcus pneumoniae. JAMA 275:194-198.
24. Ponka, A., and M. Leinonen. 1982. Adverse reactions to polyvalent pneumococcal vaccine. Scand. J. Infect. Dis. 14:67-71.
25. Powers, D. C., E. L. Anderson, K. Lottenbach, and C. M. Mink. 1996. Reactogenicity and immunogenicity of a protein-conjugated pneumococcal oligosaccharide vaccine in older adults. J. Infect. Dis. 173:1014-1018.
26. Quataert, S. A., C. S. Kirch, L. J. Quackenbush Wiedl, D. C. Phipps, S. Strohmeyer, C. O. Cimino, J. Skuse, and D. V. Madore. 1995. Assignment of weight-based antibody units to a human antipneumococcal standard reference serum, lot 89-S. Clin. Diagn. Lab. Immunol. 2:590-597.
27. Riley, I. D., P. I. Tarr, M. Andrews, M. Pfeiffer, R. Howard, P. Challands, G. Jennison, and R. M. Douglas. 1977. Immunisation with a polyvalent pneumococcal vaccine: reduction of adult respiratory mortality in a New Guinea highlands community. Lancet i:1338-1341.
28. Robbins, J. B., and R. Schneerson. 1990. Polysaccharide-protein conjugates: a new generation of vaccines. J. Infect. Dis. 161:821-832.
29. Sankilampi, U., P. O. Honkanen, A. Bloigu, E. Herva, and M. Leinonen. 1996. Antibody response to pneumococcal capsular polysaccharide vaccine in the elderly. J. Infect. Dis. 173:387-393.
30. Sanas, H., N. Rautonen, S. Sipinen, and O. Makela. 1989. IgG subclasses of pneumococcal antibodies - effect of allotype G2m(n). Scand. J. Immunol. 29:229-237.
31. Shapiro, E. D., A. T. Berg, R. Austrian, D. Shroeder, V. Parcells, A. Margolis, R. Adair, and J. D. Clemens. 1991. The protective efficacy of polyvalent pneumococcal polysaccharide vaccine. N. Engl. J. Med. 325:1453-1460.
32. Siber, G. R. 1994. Pneumococcal disease: prospects for a new generation of vaccines. Science 265:1385-1387.
33. Smit, P., D. Oberholzer, S. Hayden-Smith, H. J. Koornhof, and M. R. Hilleman. 1977. Protective efficacy of pneumococcal polysaccharide vaccines. JAMA 238:2613-2616.
34. Treanor, J. J., R. F. Betts, G. E. Smith, E. L. Anderson, C. S. Hackett, B. E. Wilkinson, R. B. Beshe, and D. C. Powers. 1996. Evaluation of a recombinant hemagglutinin expressed in insect cells as an influenza vaccine in young and elderly adults. J. Infect. Dis. 173:1467-1470.